References
- Tufail M, Wu C. Cancer Statistics in Pakistan From 1994 to 2021: Data From Cancer Registry. JCO Clin Cancer Inform. 2023;7. doi:10.1200/CCI.22.00142
- Lei S, Zheng R, Zhang S, et al. Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (Lond). 2021;41(11):1183–1194. doi:10.1002/cac2.12207
- Vaz-Luis I, Winer EP, Lin NU. Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?. Ann Oncol. 2013;24(2):283–291. doi:10.1093/annonc/mds286
- Arteaga CL, Sliwkowski MX, Osborne CK, et al. Treatment of HER2-positive breast cancer: current status and future perspectives. Nat Rev Clin Oncol. 2011;9(1):16–32. doi:10.1038/nrclinonc.2011.177
- Baddley JW, Andes DR, Marr KA, et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis. 2010;50(12):1559–1567. doi:10.1086/652768
- Slamon DJ, et al. Adjuvant Trastuzumab in HER2-Positive Breast Cancer. N Engl J Med. 2011;365(14):1273–1283.
- O’Shaughnessy J, Gradishar W, O’Regan R, Gadi V. Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics. Clin Breast Cancer. 2023;23(4):350–362. doi:10.1016/j.clbc.2023.03.007
- Peng L, Zhang Z, Zhao D, et al. Discordance in ER, PR, HER2, and Ki-67 Expression Between Primary and Recurrent/Metastatic Lesions in Patients with Primary Early Stage Breast Cancer and the Clinical Significance: Retrospective Analysis of 75 Cases. Pathol Oncol Res. 2021;27:599894. doi:10.3389/pore.2021.599894
- Patanaphan V, Salazar OM, Risco R. Breast cancer: metastatic patterns and their prognosis. South Med J. 1988;81(9): 1109–1112.
- Bai X, Luo J. Invasive Candidiasis in Patients with Solid Tumors: A Single-Center Retrospective Study. Int J Gen Med. 2023;16:2419–2426. doi:10.2147/IJGM.S411
- Mousset S, Buchheidt D, Heinz W, et al. Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2014;93(1):13–32. doi:10.1007/s00277-013-1867-1
- Tzeng Y-L, et al. Strategies to Improve Access to Targeted Therapy in Low-Resource Settings. Global Health Action. 2019;12(1):1584520.